Login / Signup

Gut Microbiota: Potential Therapeutic Target for Sickle Cell Disease Pain and Complications.

Tarimoboere AgbalalahDoofan BurEzinne Janefrances NwonuAdekunle Babajide Rowaiye
Published in: Anemia (2024)
Further exploration and clinical trials are needed to harness the full potential of these gut bacteria for individuals affected by this challenging condition.
Keyphrases
  • sickle cell disease
  • clinical trial
  • human health
  • neuropathic pain
  • risk assessment
  • spinal cord
  • open label
  • phase iii
  • postoperative pain